Henderson Jeffrey William

Halozyme Therapeutics, Inc. · Director

Henderson Jeffrey William is listed in public filings as director. This Henderson Jeffrey William insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Halozyme Therapeutics, Inc. (HALO), QUALCOMM Inc (QCOM), and Becton Dickinson and Co (BDX). Investors use Henderson Jeffrey William's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

History Trades

CompanyValueActionPriceCurrent Price
Halozyme Therapeutics, Inc.HALO$32k503 sharesSellApr 1, 2025$64.05--
Halozyme Therapeutics, Inc.HALO$189k3.2k sharesSellMar 3, 2025$59.12--
Halozyme Therapeutics, Inc.HALO$104k1.8k sharesSellMar 3, 2025$57.93--
Becton Dickinson and CoBDX$350k1.5k sharesBuyFeb 10, 2025$233.62--
Henderson Jeffrey William History Trades | TradingNote